A diagnosis of cancer and subsequent treatments place demands on psychological adaptation. Behavioral research suggests the importance of cognitive, behavioral, and social factors in facilitating adaptation during active treatment and throughout cancer survivorship, which forms the rationale for the use of many psychosocial interventions in cancer patients. This cancer experience may also affect physiological adaptation systems (e.g., neuroendocrine) in parallel with psychological adaptation changes (negative affect). Changes in adaptation may alter tumor growth-promoting processes (increased angiogenesis, migration and invasion, and inflammation) and tumor defense processes (decreased cellular immunity) relevant for cancer progression and the quality of life of cancer patients. Some evidence suggests that psychosocial intervention can improve psychological and physiological adaptation indicators in cancer patients. However, less is known about whether these interventions can influence tumor activity and tumor growth-promoting processes and whether changes in these processes could explain the psychosocial intervention effects on recurrence and survival documented to date. Documenting that psychosocial interventions can modulate molecular activities (e.g., transcriptional indicators of cell signaling) that govern tumor promoting and tumor defense processes on the one hand, and clinical disease course on the other is a key challenge for biobehavioral oncology research. This mini-review will summarize current knowledge on psychological and physiological adaptation processes affected throughout the stress of the cancer experience, and the effects of psychosocial interventions on psychological adaptation, cancer disease progression, and changes in stress-related biobehavioral processes that may mediate intervention effects on clinical cancer outcomes. Very recent intervention work in breast cancer will be used to illuminate emerging trends in molecular probes of interest in the hope of highlighting future paths that could move the field of biobehavioral oncology intervention research forward.
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1. Psychological adaptation during the cancer experience
Psychological challenges in cancer
A diagnosis of cancer and its treatments are stressful. Chief concerns of patients once diagnosed with cancer involve fears of recurrence, being damaged by adjuvant therapy, not seeing children grow, premature death, and loss of social ties and activities (Stanton, 2006; Spencer et al., 1999) . Emotional distress and negative affect states are common after a cancer diagnosis and treatment and contribute to poorer psychological well being especially if persisting after treatment (Cordova et al., 1995) . Frequently reported psychosocial phenomena during the cancer experience include increased anxiety, depressed mood, social disruption, and sleep and fatigueassociated disruption (Ganz et al., 2002; Stanton, 2006) . Although quality of life (QoL) generally improves markedly after cancer treatment and into the survivorship period (Bloom et al., 2007) , this is not always the case (Stein et al., 2008) . Poorer psychological adaptation after diagnosis and during treatment predicts diminished QoL many years later (Carver et al., 2005; Steginga et al., 2009; Wenzel et al., 2005) and may be associated with physiological processes (e.g., neuroendocrine and immune system regulation) relevant for their health status and QoL (Antoni et al., 2006a,b) . 
